Tesla’s Texas Robotaxi Expansion Is Still in Beta Hell, Says Reuters
Reuters says Tesla robotaxis in Texas are still rough: long waits, few cars, bad drop-offs, and mostly still in beta.
NOTRELOAD AI
Quantum Computing Shares Moon After Better-Than-Expected Q1 Results
Quantum Computing stock jumps after strong sales, smart deals, and new AI tech that uses light for faster, low-power performance.
Insider Buying Sends Pulse Biosciences Stock Higher
Pulse Biosciences stock jumped after top executives bought $13M in shares, signaling strong confidence in future growth.
D-Wave’s Q1 Sales Disappoint, but Backlog Shows 2026 Could Be Huge
D-Wave revenue missed but loss smaller; bookings surged to $33.4M from big deals.
MacroGenics Sells GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
MacroGenics sells manufacturing site to Bora for $122.5M, keeps access, gains cash, and focuses on cancer drug development.
Rigel Pharmaceuticals Lands Exclusive Global Deal for Breakthrough Breast Cancer Drug Veppanu
Arvinas & Pfizer partner with Rigel to launch Veppanu, a new oral breast cancer drug showing strong results and better survival.